Key facts
- This page summarizes Thomas J. Riga's Form 4 filing for SPECTRUM PHARMACEUTICALS INC.
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Jan 2023, 18:50.
Thomas J. Riga - 03 Jan 2023 Form 4 Insider Report for SPECTRUM PHARMACEUTICALS INC
- Reporting relationship
- CEO & President, Director
- Issuer ticker
- N/A
- Reported as of
- 03 Jan 2023
- Net transaction value
- -$9,141
- SEC form
- 4
- Accepted by SEC
- 05 Jan 2023, 18:50:21 UTC
- Prior SEC filing
- 13 Feb 2023
- Next SEC filing
- 01 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Keith M. McGahan, Attorney-in-Fact for Thomas J. Riga
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas J. Riga filed Form 4 for SPECTRUM PHARMACEUTICALS INC on 05 Jan 2023.
Change
- Previous filing in this sequence was filed on 13 Feb 2023.
- Current net transaction value: -$9,141.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SPPI
transaction
Common Stock, $0.001 par value
Sale
- Transaction value
- $9,141
- Shares
- -23,929
- Change %
- -2%
- Price
- $0.3820
- Shares after
- 1,189,411
- Date
- 03 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
SPPI
transaction
Common Stock, $0.001 par value
Award
- Transaction value
- $0
- Shares
- +888,000
- Change %
- +75%
- Price
- $0.000000
- Shares after
- 2,077,411
- Date
- 03 Jan 2023
- Ownership
- Direct
- Footnotes
- F2
SPPI
holding
Common Stock, $0.001 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 14,139
- Date
- 03 Jan 2023
- Ownership
- By 401(k) plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SPPI
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +3,112,000
- Change %
- Price
- $0.000000
- Shares after
- 3,112,000
- Date
- 03 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,112,000
- Exercise price
- $0.3800
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
Footnote F2
One third of the aggregate amount of restricted stock units shall vest on each of January 3, 2024, 2025 and 2026, respectively.
Footnote F3
One third of the aggregate amount of option shares shall vest on each of January 3, 2024, 2025 and 2026, respectively.